Methods for cyclic nucleotide determination

US10000792B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10000792-B2
Application numberUS-71008710-A
CountryUS
Kind codeB2
Filing dateFeb 22, 2010
Priority dateDec 6, 2005
Publication dateJun 19, 2018
Grant dateJun 19, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates in general to cellular analysis tools and more particularly to methods for detecting or determining cyclic nucleotide concentrations in samples. Samples containing cyclic nucleotides may be contacted with a cyclic nucleotide-dependent protein kinase and a detection system which includes a substrate for the cyclic nucleotide-dependent protein kinase. The activities in cyclic nucleotide related pathways may be measured using the detection system.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for determining the presence or amount of endogenous cyclic nucleotide in a sample comprising a cell lysate, the method comprising: a) contacting a sample comprising a cell lysate which may contain endogenous cyclic nucleotide, with (I) a cyclic nucleotide-dependent protein kinase capable of being activated by the endogenous cyclic nucleotide, wherein said protein kinase is Protein Kinase A and (II) a detection system, the detection system comprising: i) a substrate capable of being phosphorylated by the cyclic nucleotide-dependent protein kinase; ii) a luciferase enzyme capable of utilizing ATP to generate a bioluminescent signal; and (iii) ATP; and b) detecting or measuring the bioluminescent signal thereby determining the presence or amount of the endogenous cyclic nucleotide present in the sample, wherein the cell lysate comprises the cellular debris and fluid that is released from a cell when the cell membrane is broken apart or lysed, wherein the endogenous cyclic nucleotide is cAMP. 2. The method of claim 1 , wherein the lysate is derived from eukaryotic cells. 3. The method of claim 1 , wherein the lysate is derived from mammalian cells. 4. The method of claim 1 , comprising determining the amount of the endogenous cyclic nucleotide in the sample based on the amount of change in the bioluminescent signal when compared to a standard curve of cyclic nucleotide concentration versus luminescence. 5. The method of claim 1 , wherein the sample comprises plasma membranes. 6. The method of claim 1 , wherein the substrate comprises SEQ ID NO:1. 7. The method of claim 1 , wherein the presence or amount of cAMP present is determined by comparing the bioluminescent signal to a standard curve of cAMP concentration versus luminescence. 8. The method of claim 1 , wherein the sample may contain adenylyl cyclase and further comprising determining from measuring the bioluminescent signal of step (b) the adenylyl cyclase activity present in the sample based on the presence or amount of the endogenous cyclic nucleotide. 9. The method of claim 1 , wherein the sample may contain G-protein coupled receptor and further comprising determining from measuring the bioluminescent signal of step (b) the activity of a G-protein coupled receptor present in the sample based on the presence or amount of the endogenous cyclic nucleotide. 10. The method of claim 1 , wherein the sample is incubated with the cyclic nucleotide-dependent protein kinase, the substrate and ATP prior to being contacted with the luciferase enzyme. 11. The method of claim 10 , wherein the substrate comprises kemptide.

Assignees

Inventors

Classifications

  • HIV-1, HIV-2 · CPC title

  • G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH · CPC title

  • involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors} · CPC title

  • Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase · CPC title

  • involving luciferase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10000792B2 cover?
The present invention relates in general to cellular analysis tools and more particularly to methods for detecting or determining cyclic nucleotide concentrations in samples. Samples containing cyclic nucleotides may be contacted with a cyclic nucleotide-dependent protein kinase and a detection system which includes a substrate for the cyclic nucleotide-dependent protein kinase. The activities …
Who is the assignee on this patent?
Goueli Said A, Hsiao Kuei Hsuan, Kumar Meera, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12Q1/485. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).